Notification of Transactions of Directors, Persons Discharging
Managerial Responsibility or Connected Persons
The Administrators of the GlaxoSmithKline 2009 Deferred Annual Bonus Plan (the "Plan") notified the Company and the under-mentioned persons on 10 January 2012 of an increase in their notional interests in Ordinary share ADRs at a price of $46.24 per share following the re-investment of dividends paid to shareholders on 5 January 2012.
Mrs D P Connelly |
Acquisition of 9.310 ADRs under the personal contribution element of the Plan. |
|
|
Mr W C Louv
|
Acquisition of 9.574 ADRs under the matching element of the Plan (Company contribution).
Acquisition of 24.623 ADRs under the personal contribution element of the Plan.
Acquisition of 25.138 ADRs under the matching element of the Plan (Company contribution).
|
The notional dividends accrued will be paid out in proportion to the percentage of the participant's deferred annual bonus holdings that will vest following the end of the relevant three year measurement period.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
10 January 2012